Chemoinformaics analysis of HEPTADECANOIC-ACID
| Molecular Weight | 270.457 | nRot | 15 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 1 |
| Exact Molecular Weight | 270.256 | nRing | 0 |
| Solubility: LogS | -5.591 | nHRing | 0 |
| Solubility: LogP | 7.154 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 52.665 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.374 |
| Synth | 1.682 |
| Natural Product Likeliness | 0.365 |
| NR-PPAR-gamma | 0.979 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -5.053 |
| MDCK | 0.0000228 |
| BBB | 0.042 |
| PPB | 0.991967 |
| VDSS | 0.69 |
| FU | 0.00936512 |
| CYP1A2-inh | 0.293 |
| CYP1A2-sub | 0.189 |
| CYP2c19-inh | 0.247 |
| CYP2c19-sub | 0.077 |
| CYP2c9-inh | 0.146 |
| CYP2c9-sub | 0.99 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.048 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.016 |
| CL | 2.399 |
| T12 | 0.542 |
| hERG | 0.065 |
| Ames | 0.005 |
| ROA | 0.026 |
| SkinSen | 0.92 |
| Carcinogencity | 0.058 |
| EI | 0.972 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.052 |
| Antiviral | Yes |
| Prediction | 0.667567 |